249
Views
22
CrossRef citations to date
0
Altmetric
Comprehensive Review

Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs

&
Pages 39-48 | Received 24 Jul 2003, Accepted 05 Feb 2004, Published online: 12 Jul 2009

References

  • Kandel DB, ed. Stages and pathways of drug involvement: examining the gateway hypothesis. New York: Cambridge University Press, 2002.
  • DuPont RL. Getting tough on gateway drugs: a guide for the family. Washington, DC: American Psychiatric Press, 1984.
  • Polich JM, Ellickson PL, Reuter P, Kahan JP. Strategies for controlling adolescent drug use. Santa Monica, CA: Rand Corporation, 1984.
  • de Kort M, Cramer T. Pragmatism versus ideology: Dutch drug policy continued. J Drug Issues 1999;29(3):473–492.
  • Morral AR, McCaffrey DF, Paddock SM. Reassessing the marijuana gateway effect. Addiction 2002;97(12):1493–504.
  • Kandel D. Stages in adolescent involvement in drug use. Science 1975;190:912–914.
  • Golub A, Johnson BD. Substance use progression and hard drug use in inner-city New York. In: Kandel DB, ed. Stages and pathways of drug involvement: examining the gateway hypothesis. Cambridge, UK: Cambridge University Press, 2002:p. 90–112.
  • Kandel DB. Marijuana users in young adulthood. Arch Gen Psychiatry 1984;41(2):200–9.
  • Donnelly N, Hall WD. Patterns of cannabis use in Australia. Canberra: Australian Government Publishing Service, 1994.
  • Donovan JE, Jessor R. Problem drinking and the dimension of involvement with drugs: a Guttman scalogram analysis of adolescent drug use. Am J Public Health 1983;73(5):543–52.
  • Kandel DB. Issues of sequencing of adolescent drug use and other problem behaviors. Drugs Soc 1988; 3 (1-2): 55–76.
  • Kandel DB. Convergences in prospective longitudinal surveys of drug use in normal populations. In: Kandel DB, ed. Longitudinal research on drug use: empirical findings and methodological issues. New York: John Wiley, 1978:p. 3–38.
  • Robins L, Darvish HS, Murphy GE. The long-term outcome for adolescent drug users: a follow-up study of 76 users and146 nonusers. In: Zubin J, Freedman AM, eds. The psychopathology of adolescence. New York: Grune and Stratton, 1970.
  • Kandel DB, Davies M, Karus D, Yamaguchi K. The consequences in young adulthood of adolescent drug involvement: an overview. Arch Gen Psychiatry 1986;43(8):746–754.
  • Kandel DB, Yamaguchi K. Stages of drug involvement in the U.S. population. In: Kandel DB, ed. Stages and pathways of drug involvement: examining the gateway hypothesis. New York: Cambridge University Press, 2002:p. 65–89.
  • Kaplan HB, Martin SS, Robbins C. Pathways to adolescent drug use: self-derogation, peer in fluence, weakening of social controls, and early substance use. J Health Soc Behav 1984;25(3):270–289.
  • Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood: III. Predictors of progres-sion. Am J Public Health 1984;74(7):673–81.
  • Yamaguchi K, Kandel DB. Patterns of drug use from adolescence to young adulthood: II. Sequences of progres-sion. Am J Public Health 1984;74(7):668–72.
  • Fergusson DM, Horwood LJ. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997;92(3):279–296.
  • Fergusson DM, Horwood LJ. Prospective childhood pre-dictors of deviant peer af filiations in adolescence. J Child Psychol Psychiatry 1999;40(4):581–592.
  • Fergusson DM, Horwood LJ. Does cannabis use encourage other forms of illicit drug use? Addiction 2000;95(4):505–520.
  • McGee R, Feehan M. Cannabis use among New Zealand adolescents. N Z Med J 1993;106(961):345.
  • MacCoun R. In what sense (if any) is marijuana a gateway drug? FAS Drug Policy Anal Bull 1998;4.
  • Hall WD. A simpli fied logic of causal inference. Aust N Z J Psychiatry 1987;21(4):507–513.
  • Hill A. A short textbook of statistics. London: Hodder and Stoughton, 1977.
  • Goode E. Marijuana use and the progression to dangerous drugs. In: Miller LL, ed. Marijuana: effects on human behavior. New York: Academic Press, 1974:p. 303–338.
  • Robins LN. Vietnam veterans’ rapid recovery from heroin addiction: a fluke or normal expectation? Addiction 1993;88(8):1041–1054.
  • Cohen S. Drug use: religion and secularization. Am J Psychiatry 1972;129(1):97.
  • Wagner FA, Anthony JC. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epide-miol 2002;155(10):918–925.
  • van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002;156(4):319–327.
  • Bartels M, Hudziak JJ, van den Oord EJ, van Beijsterveldt CE, Tietveld MJ, Moomsma DI. Co-occurrence of aggres-sive behavior and rule-breaking behavior at age 12: multi-rater analyses. Behav Genet 2003;33:607–621.
  • Newcomb MD, Bentler PM. Consequences of adolescent drug use: impact on the lives of young adults. Thousand Oaks, CA: Sage, 1988.
  • Jessor R, Jessor SL. Problem behavior and psychosocial development: a longitudinal study of youth. New York: Academic Press, 1977.
  • Osgood DW, Johnston LD, O’Malley PM, Bachman JG. The generality of deviance in late adolescence and early adulthood. Am Sociol Rev 1988;53(1):81–93.
  • Shedler J, Block J. Adolescent drug use and psychological health: a longitudinal inquiry. Am Psychol 1990;45(5):612–630.
  • Brook JS, Cohen P, Whiteman M, Gordon AS. Psychoso-cial risk factors in the transition from moderate to heavy use or abuse of drugs. In: Glantz MD, ed. Vulnerability to drug abuse. Washington, DC: American Psychological Associa-tion, 1992:p. 359–388.
  • Jessor R, Jessor SL. Theory testing in longitudinal research on marijuana use. In: Kandel DB, ed. Longitudinal research on drug use: empirical findings and methodological issues. New York: John Wiley, 1978:p. 41–71.
  • Bailey SL, Flewelling RL, Rachal JV. Predicting continued use of marijuana among adolescents: the relative in fluence of drug-speci fic and social context factors. J Health Soc Behav 1992;33(1):51–66.
  • Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 1992;112(1):64–105.
  • Kandel DB, Davies M. Progression to regular marijuana involvement: phenomenology and risk factors for near-daily use. In: Glantz MD, ed. Vulnerability to drug abuse. Washington, DC: American Psychological Association, 1992:p. 211–253.
  • Kaplan HB, Johnson RJ. Relationships between circum-stances surrounding initial illicit drug use and escalation of drug use: moderating effects of gender and early adolescent experiences. In: Glantz MD, Pickens RW, eds. Vulner-ability to drug abuse. Washington, DC: American Psychological Association, 1992:p. 299–358.
  • Newcomb MD. Understanding the multidimensional nat-ure of drug use and abuse: the role of consumption, risk factors, and protective factors. In: Glantz MD, ed. Vulner-ability to drug abuse. Washington, DC: American Psychological Association, 1992:p. 255-297.
  • Scheier LM, Newcomb MD. Psychosocial predictors of drug use initiation and escalation: an expansion of the multiple risk factors hypothesis using longitudinal data. Contemp Drug Probl 1991; 18(1):31–73.
  • O’Donnell JA, Clayton RR. The stepping stone hypothesis -marijuana, heroin, and causality. Chem Depend Behav Biomed Issues 1982;4(3):229–241.
  • Fergusson DM, Horword LJ, Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002;97:1123–1135.
  • Heath AC. Genetic in fluences on alcoholism risk: a review of adoption and twin studies. Alcohol Health Res World 1995;19(3):166–171.
  • Kendler KS, Prescott CA. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 1998;155(8):1016–1022.
  • Han C, McGue MK, Iacono WG. Lifetime tobacco, alcohol and other substance use in adolescent Minnesota twins: univariate and multivariate behavioral genetic analyses. Addiction 1999;94(7):981–993.
  • True WR, Heath AC, Scherrer JF, Xian H, Lin N, Eisen SA, et al. Interrelationship of genetic and environmental in fluences on conduct disorder and alcohol and marijuana dependence symptoms. Am J Med Genet 1999;88(4):391–7.
  • Kendler KS, Jacobson KC, Prescott CA, Neale MC. Speci ficity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucino-gens, sedatives, stimulants, and opiates in male twins. Am J Psychiatry 2003;160(4):687–95.
  • Lynskey MT, Heath AC, Bucholz KK, Slutske WS. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA-J Am Med Assoc 2003;289(4):427–433.
  • Nahas GG. Keep off the grass. 5th ed. Middlebury, VT: Paul Eriksson, 1990.
  • Walters E. Marijuana: an Australian crisis. Malvern, VIC: Walters, 1993.
  • Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997;276(5321):2048–2050.
  • Gardner EL. Cannabinoid interaction with brain reward systems. In: Nahas G, Sutin KM, Harvey D, Agurell S, eds. Marihuana and medicine. Towa, NJ: Humana Press, 1999:p. 187–205.
  • Manzanares J, Corchero J, Romero J, Fernandez-Ruiz JJ, Ramos JA, Fuentes JA. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 1999;20:287–294.
  • Ledent CM, Valverde O, Cossu G, Petitet F, Aubert JF, Beslot F, et al. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in cb1 receptor knock-out mice. Science 1999;283:401–404.
  • De Fonseca FR, Carrera MR, Navarro M, Koob GF, Weiss Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 1997;276:2050–2054.
  • Zimmer L, Morgan JP. Marijuana myths, marijuana facts: a review of the scienti fic evidence. New York: The Linde-smith Center, 1997.
  • Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G. Behavioural sensitization after repeated exposure to [del-ta]9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) 2001;158(3):259–266.
  • Lamarque S, Taghzouti K, Simon H. Chronic treatment with [delta] 9-tetrahydrocannabinol enhances the locomo-tor response to amphetamine and heroin: implications for vulnerability to drug addiction. Neuropharmacology 2001;41(1):118–129.
  • Lynskey M. An alternative model is feasible, but the gateway hypothesis has not been invalidated: comments on Morral et al. Addiction 2002;97(12):1505–7.
  • Botvin GJ, Scheier LM, Grif fin KW. Preventing the onset and developmental progression of adolescent drug use: implications for the gateway hypothesis. In: Kandel DB, ed. Stages and pathways of drug involvement: examining the gateway hypothesis. New York: Cambridge University Press, 2002:p. 115–138.
  • Gerstein DR, Green LW, eds. Preventing drug abuse: what do we know? Washington, DC: National Academy Press, 1993.
  • Manski CF, Pepper JV, Petrie CV, eds. Informing America’s policy on illegal drugs: what we don’t know keeps hurting us. Washington, DC: National Academy Press, 2001.
  • Caulkins JP, Rydell CP, Everingham SMS, Chiesa JR, Bushway S. An ounce of prevention, a pound of uncer-tainty: the cost-effectiveness of school-based drug prevention programs. Santa Monica, CA: Rand Corpora-tion, 1999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.